(...)Our governments have chosen, over decades, to allow a strange system for developing medicines to build up. Most of the work carried out by scientists to bring a drug to your local pharmacist - and into your lungs, or stomach, or bowels - is done in government-funded university labs, paid for by your taxes. Drug companies usually come in late in the process of development, and pay for part of the expensive, but largely uncreative final stages, like buying some of the chemicals and trials that are needed. In return, then they own the exclusive rights to manufacture and profit from the resulting medicine for years. Nobody else can make it.
(...)But a detailed study by Dr Marcia Angell, the former editor of the prestigious New England Journal of Medicine, says that only 14 per cent of their budgets go on developing drugs - usually at the uncreative final part of the drug-trail. The rest goes on marketing and profits. And even with that puny 14 per cent, drug companies squander a fortune developing "me-too" drugs - medicines that do exactly the same job as a drug that already exists, but has one molecule different, so they can take out a new patent, and receive another avalanche of profits.

Harvard University is at the centre of an academic and political scandal after three prominent members of its psychiatry department were accused of breaking conflict-of-interest rules by failing to declare millions of dollars in consulting fees from drugs manufacturers.

africa and philanthropy:
In addition to providing raw materials, labor, and markets for finished products, Africa also cleanses the conscience of Africanist scholars, evangelists and missionaries, the rock and roll musicians who want to save Africa through orphan adoption, and philanthropists with Mother-Theresa complexes. But at the top of the pack – Western politicians. Occupy Iraq and Afghanistan but do not forget to rescue the African from the clutches of war-lords, poverty, corruption, and disease. Africa has become the continent where the guilt-ridden come to score quick moral points. And we let them.
(...) When Tony Blair intervened in Sierra Leone, it was heralded as an emblem of humanitarian military intervention (one of the five tenets of what became known as the Blair Doctrine). Yet, as Blair prepares to leave office, the reality in Sierra Leone is far different from the success story that will become part of his legacy. . Sierra Leone remains one of the world’s poorest nations. As the BBC reports on its website, 60 percent of its budget is met through foreign aid, life expectancy is 41 years and 70 percent of the population lives below the poverty line. Even with debt forgiveness Sierra Leone continues to import more than it exports – all testaments to a radical dependency and inequality in an otherwise resource-rich nation. This is a recipe for another civil war long after Blair is out of office.
(...)For Bush, as the United States foreign policy suffers defeat in the Middle East, Africa becomes the saving grace. Its working - the Washington Post recently applauded Bush for his War on AIDS. But according to Africa Action’s Salih Booker, since 2002 Bush’s AIDS Plan has been “more smoke than mirrors.” Instead of allocating the promised money through the Global Fund, he channels it through PEPFAR, the President’s Emergency Plan for AIDS Relief which is “often influenced by restrictive and ideologically-based policy prescriptions, such as abstinence-only regulations.” Bush undermines his own efforts through what most experts understand as unworkable ABC programs (Abstinence, Being Faithful and as a last resort, Condoms).
(...) Worse is the AIDS-Industrial Complex. The US under Bush opposed the loosening of patent laws which would allow countries to manufacture or import generic drugs. Donated AIDS money is therefore being spent on expensive premium drugs. The pharmaceutical companies pocket the money then lobby against the loosening of patent laws. The system is locked into a cycle of profit making at the expense of the dying.
(...) In what other parts of the world call corruption, a study by Public Campaign found that in the United States, between 1999 and 2004 “health care related interests [have] contributed $162.3 million dollars to federal candidates and party committees.” In 2003 President Bush appointed Randall Tobias, CEO of Eli Lilly & Co (a large US Pharmaceutical company) to head the U.S. Global AIDS Coordinator.
(...) To put things in perspective consider the following: Africa as a continent, with an estimated population of 680 million people receives 4.5 billion dollars from the United States while the country of Israel, with a population of 6 million, receives about 3 billion. And as Bush spends about 4.5 Billion a year on AIDS in Africa, for the fiscal year 2008, he has asked congress for $624.6 billion to be spent on the military.
(...) According to an Oxfam report, for every dollar given to Africa in aid, the donors get two dollars back. Oxfam also reports that a “one percent increase in trade for Africa would bring $70 billion into the continent – five times as much as Africa currently receives in aid and debt relief.”
(...) Because of the US 49 billion and the EU 93 billion on farmer subsidies, Africa, as a result of cheaper international prices, loses more than it gets in foreign aid. A United Nations African Renewal article shows Mali received 37.7 million in US aid in 2001, but lost 43 million dollars through cheap market prices. The US was taking more with one hand and giving less with other.
(...) But we as Africans also have to take a good share of the blame. Instead of policies that would once and for all break our dependency, our leaders trade our long-term livelihood for short-term gains. In 2003, according to Patrick Bond, a political analyst based in South Africa, the African elite had $80 billion sitting in Western banks. At the same time African governments owed these same banks $30 billion. Or in another startling statistic, between 1970 and 1996, Africa lost $285 billion as a result of capital flight while incurring a $178 billion debt.
(...)